JP2019524871A5 - - Google Patents

Download PDF

Info

Publication number
JP2019524871A5
JP2019524871A5 JP2019517203A JP2019517203A JP2019524871A5 JP 2019524871 A5 JP2019524871 A5 JP 2019524871A5 JP 2019517203 A JP2019517203 A JP 2019517203A JP 2019517203 A JP2019517203 A JP 2019517203A JP 2019524871 A5 JP2019524871 A5 JP 2019524871A5
Authority
JP
Japan
Prior art keywords
conjugate
pharmaceutical composition
group
peg
attached
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019517203A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019524871A (ja
JP7081832B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/037303 external-priority patent/WO2017218569A2/en
Publication of JP2019524871A publication Critical patent/JP2019524871A/ja
Publication of JP2019524871A5 publication Critical patent/JP2019524871A5/ja
Application granted granted Critical
Publication of JP7081832B2 publication Critical patent/JP7081832B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019517203A 2016-06-13 2017-06-13 α（Ｖ）β（６）インテグリン結合ペプチドおよびその使用方法 Active JP7081832B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662349615P 2016-06-13 2016-06-13
US62/349,615 2016-06-13
PCT/US2017/037303 WO2017218569A2 (en) 2016-06-13 2017-06-13 Alpha(v)beta(6) integrin-binding peptides and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2019524871A JP2019524871A (ja) 2019-09-05
JP2019524871A5 true JP2019524871A5 (enExample) 2021-04-22
JP7081832B2 JP7081832B2 (ja) 2022-06-07

Family

ID=60664208

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019517203A Active JP7081832B2 (ja) 2016-06-13 2017-06-13 α（Ｖ）β（６）インテグリン結合ペプチドおよびその使用方法

Country Status (7)

Country Link
US (2) US11185601B2 (enExample)
EP (1) EP3468984A4 (enExample)
JP (1) JP7081832B2 (enExample)
CN (1) CN109563135B (enExample)
AU (1) AU2017283537B2 (enExample)
CA (1) CA3027364A1 (enExample)
WO (1) WO2017218569A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2945945C (en) * 2014-04-15 2023-10-03 The Regents Of The University Of California Bi-terminal pegylated integrin-binding peptides and methods of use thereof
AU2017283537B2 (en) 2016-06-13 2021-11-11 The Regents Of The University Of California Alpha(V)beta(6) integrin-binding peptides and methods of use thereof
EP3846858A4 (en) 2018-09-07 2022-10-19 The Regents of the University of California Alpha(v)beta(6) integrin-binding peptides and methods of use thereof
US20220348609A1 (en) * 2019-10-25 2022-11-03 University Of Washington Computational design of alpha(v) beta (6) integrin binding proteins
EP4090667A1 (en) * 2020-01-21 2022-11-23 Quantum-si Incorporated Compounds and methods for selective c-terminal labeling
EP4117736A1 (en) * 2020-03-12 2023-01-18 Technische Universität München Cyclic peptides and their conjugates for addressing alpha-v-beta-6 integrin in vivo
KR20230117581A (ko) * 2020-12-04 2023-08-08 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 펩티드 수용체 방사성 핵종 요법
EP4637731A1 (en) 2022-12-21 2025-10-29 Gilead Sciences, Inc. Combination therapy for treating cancer
WO2024263637A1 (en) 2023-06-20 2024-12-26 The Regents Of The University Of California Combination therapy with peptide receptor radionuclide and dna repair inhibitor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5429133A (en) * 1992-12-18 1995-07-04 Neoprobe Corporation Radiation responsive laparoscopic instrument
DE10154180A1 (de) * 2001-11-05 2003-05-15 Basf Ag gene die für genetische Stabilitäts-, genexpressions-und Faltungsproteine codieren
DE602004023534D1 (de) 2003-11-18 2009-11-19 Mitsubishi Gas Chemical Co Verfahren zur herstellung von optisch aktivem 2-alkylcystein, derivate davon und herstellungsverfahren
GB0520068D0 (en) * 2005-10-03 2005-11-09 Cancer Res Technology av peptide ligand
GB0718967D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Peptide imaging agents
CA2945945C (en) * 2014-04-15 2023-10-03 The Regents Of The University Of California Bi-terminal pegylated integrin-binding peptides and methods of use thereof
AU2017283537B2 (en) 2016-06-13 2021-11-11 The Regents Of The University Of California Alpha(V)beta(6) integrin-binding peptides and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2019524871A5 (enExample)
JP2017513859A5 (enExample)
JP6666264B2 (ja) 新規安定型抗体薬物複合体の作製およびその応用
ES2627822T3 (es) Péptidos de penetración celular para administración intracelular de moléculas
US8637635B2 (en) Peptides that selectively home to heart vasculature and related conjugates and methods
Li et al. Potent retro-inverso D-peptide for simultaneous targeting of angiogenic blood vasculature and tumor cells
CN104262460B (zh) 一种靶向人乳腺癌细胞的多肽及其应用
JP2015512246A5 (enExample)
CN106573031A (zh) 双末端聚乙二醇化整合素‑结合肽及其使用方法
KR20190039153A (ko) 악성 종양 표적 펩티드
CN105693860B (zh) 特异性靶向her2蛋白的多肽及其应用
CN105085631A (zh) 一种特异靶向her2蛋白的多肽及其应用
JP6417347B2 (ja) 心臓血管に対して選択的にホーミングするペプチド、ならびに関連する結合体および方法
KR101947529B1 (ko) Rhamm 결합 펩타이드
JP7174429B2 (ja) コラーゲンへの結合活性を有する環状ペプチド
ES2319624T3 (es) Peptidos que se dirigen al conjunto de vasos linfaticos del tumor y procedimientos de utilizacion de los mismos.
Okarvi et al. Preparation and evaluation of the tumor-specific antigen-derived synthetic mucin 1 peptide: A potential candidate for the targeting of breast carcinoma
US11971412B2 (en) Polypeptide-antibody complexes and uses thereof
JP7824885B2 (ja) 表皮水疱症の治療で使用するためのホーミングペプチド誘導デコリン複合体
WO2026022392A1 (en) Peptide and conjugates thereof
EP4568993A1 (en) Peptides for the treatment of fibrosis
US20210023233A1 (en) Antibody-peptide complexes and uses thereof
KR20150028213A (ko) 신규한 심혈관계 질환의 진단 및 치료용 펩티드